| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.04 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |